Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28138890 | 0.98 | TSHR (0.41) | TSHRSLC6A2SLC6A4SLC6A3CHRNB2 | |
| SCHEMBL6061281 | 0.90 | — | — | |
| SCHEMBL29289461 | 0.82 | TSHR (0.39) | TSHRSLC6A2SLC6A4SLC6A3CHRNB2 | |
| SCHEMBL2233573 | 0.81 | TSHR (0.38) | TSHRSLC6A2SLC6A4SLC6A3CHRNB2 | |
| SCHEMBL1694289 | 0.78 | TSHR (0.36) | TSHRSLC6A2SLC6A4SLC6A3CHRNB2 | |
| SCHEMBL28141206 | 0.77 | TSHR (0.38) | TSHRSLC6A2SLC6A4SLC6A3CHRNB2 | |
| SCHEMBL27586839 | 0.77 | TSHR (0.35) | TSHRSLC6A2SLC6A4SLC6A3KDM1A | |
| SCHEMBL913096 | 0.76 | TSHR (0.41) | TSHRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11564082 | 0.76 | HTR2C (0.36) | SLC6A2SLC6A4SLC6A3KDM1A | |
| SCHEMBL11562602 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12614943-B2 | Electrical operating means having an insulation system, and method for producing the insulation system | SIEMENS AKTIENGESELLSCHAFT (DE) | 2026-04-28 | — | — | US | claimed |
| US-20240400858-A1 | HIGH CRACK THRESHOLD PLANARIZING COATINGS AND PROCESSES TO FILL WIDE AND DEEP TRENCHES FOR SILICONE WAFERS | SOLSTICE ADVANCED MATERIALS US, INC. | 2024-12-05 | — | — | US | claimed |
| WO-2024243005-A1 | HIGH CRACK THRESHOLD PLANARIZING COATINGS AND PROCESSES TO FILL WIDE AND DEEP TRENCHES FOR SILICONE WAFERS | HONEYWELL INTERNATIONAL INC. (US) | 2024-11-28 | — | — | WO | claimed |
| CN-113730297-B | Pearlescent no-wash hair care essence | 广州市衡拓贸易有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-115778855-A | Lipstick and its preparation method | 上海臻臣化妆品有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20220029491-A1 | Electrical Operating Means Having an Insulation System, and Method for Producing the Insulation System | SIEMENS AKTIENGESELLSCHAFT (DE) | 2022-01-27 | — | — | US | claimed |
| EP-3844218-A1 | ELECTRICAL OPERATING MEANS HAVING AN INSULATION SYSTEM, AND METHOD FOR PRODUCING THE INSULATION SYSTEM | Siemens Aktiengesellschaft (DE) | 2021-07-07 | — | — | EP | claimed |
| CN-112996852-A | Electrical device with insulation system and method for producing an insulation system | 西门子股份公司 | 2021-06-18 | — | — | CN | claimed |
| US-10626435-B2 | Nanofluidic device for isolating, growing, and characterizing microbial cells | NORTHEASTERN UNIVERSITY (US) | 2020-04-21 | — | — | US | claimed |
| US-20180243344-A1 | OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2018-08-30 | — | — | US | claimed |
| CN-102300898-A | Cosmetic composition comprising an aqueous dispersion of polysiloxane/polyurea and a silane and a method for cosmetic treatment | — | 2011-12-28 | — | — | CN | claimed |
| CN-101854959-A | Silicone gel-based compositions for wound healing and scar reduction | VALEANT PHARMACEUTICALS INT | 2010-10-06 | — | — | CN | claimed |
| CN-101366687-A | Anhydrous cosmetic composition comprising a pressure-sensitive adhesive silicone copolymer, a volatile silicone and a particular fluid silicone | OREAL (FR) | 2009-02-18 | — | — | CN | claimed |
| CN-1853611-A | Polymer particle dispersion, cosmetic compositions comprising it and cosmetic process using it | OREAL (FR) | 2006-11-01 | — | — | CN | claimed |
| CN-1158061-C | Alkyl non volatile oil cosmetic composition for preventing shading | �ź㴫 | 2004-07-21 | — | — | CN | claimed |
| CN-1394134-A | Matt cosmetic composition comprising non-volatile hydrocarbon oil and inert particulate phase | OREAL (FR) | 2003-01-29 | — | — | CN | claimed |
| CN-1302596-A | Alkyl non volatile oil cosmetic composition for preventing shading | OREAL (FR) | 2001-07-11 | — | — | CN | claimed |
| CN-1240639-A | Composition of olefin copolymer comprising controlled crystallization and use of such coplymer | OREAL (FR) | 2000-01-12 | — | — | CN | claimed |
| EP-0679388-B1 | Cosmetic and/or dermatologic skin depigmentation composition and its use | OREAL (FR) | 1998-10-07 | — | — | EP | claimed |
| EP-0679388-A1 | Cosmetic and/or dermatologic skin depigmentation composition and its use | L'OREAL (FR) | 1995-11-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12614943-B2 | Electrical operating means having an insulation system, and method for producing the insulation system | SCO2, RAE1, FTO | TSHR 1696/4885SLC6A2 3497/4885SLC6A4 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.